儿科急诊科青少年的避孕使用与妊娠风险
这项多中心横断面研究(计划性二次分析)于2021年4月至2022年4月在6个隶属于儿科急诊护理应用研究网络的城区儿科三级急诊科开展,纳入1063名15至21岁、自报出生性别为女性且有阴茎-阴道性交史并完成保密性健康调查的青少年。结果显示71.1%报告上次性行为时使用避孕措施,长效可逆避孕使用率最低(15.4%),28.9%未使用任何避孕措施;总体妊娠风险指数为7.89,即每100名女性每年预期8次妊娠。108名(10.2%)符合紧急避孕条件,但仅6名(5.6%)被开具紧急避孕处方。作者认为急诊科存在提供避孕服务的高需求和潜在机会。
要点
- 在1063名性活跃青少年中,28.9%报告上次性行为未使用任何避孕措施,长效可逆避孕使用率最低(15.4%)。
- 总体妊娠风险指数为7.89,即每100名女性每年预期8次妊娠,研究人群非意愿妊娠风险近8%。
- 108名(10.2%)符合紧急避孕条件,但仅6名(5.6%)被开具紧急避孕处方。
- 与总体避孕使用及长效可逆避孕使用相关的社会人口学因素包括保险和种族与族裔。
- 作者认为急诊科存在提供避孕服务的高需求和潜在机会。
适用人群与场景
- 15至21岁、自报出生性别为女性、有阴茎-阴道性交史、完成保密性健康调查、因照护需求就诊于急诊科的个体。
- 研究场景为6个隶属于儿科急诊护理应用研究网络的城区儿科三级急诊科。
诊断标准与关键阈值
- 妊娠风险指数(PRI)总体为7.89,即每100名女性每年预期8次妊娠。
- 108名参与者(10.2%)符合紧急避孕条件。
处置流程与药物剂量
- 108名符合紧急避孕条件的参与者中,仅6名(5.6%)被开具紧急避孕处方。
研究设计与关键结果
- 研究设计为多中心横断面研究,是2021年4月至2022年4月一项多中心试验的计划性二次分析,在6个城区儿科三级急诊科使用基于平板电脑、内容经效度验证的保密性健康调查;数据分析于2023年1月至2024年2月进行。
- 共纳入1063名参与者,中位年龄17.5岁(IQR 16.5-18.3);219名(20.8%)为西班牙裔,464名(44.1%)为非西班牙裔黑人,308名(29.3%)为非西班牙裔白人,61名(5.8%)为其他种族和族裔。
- 756名参与者(71.1%)报告上次性行为时使用避孕措施;长效可逆避孕使用最少(164名,15.4%);307名(28.9%)报告未使用避孕措施。
- 与总体避孕使用及长效可逆避孕使用相关的社会人口学因素包括保险和种族与族裔。
- 总体妊娠风险指数为7.89,即每100名女性每年预期8次妊娠。
- 108名参与者(10.2%)符合紧急避孕条件,但仅6名(5.6%)被开具紧急避孕处方。
证据类型、等级与局限
- 证据类型:多中心横断面研究(计划性二次分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些数据提示急诊科存在提供避孕服务的高需求和潜在机会。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Unintended pregnancy is a major health risk for adolescents in the US, and adolescents face many barriers to obtaining effective and reliable contraception.
OBJECTIVE: To measure and describe the use of contraception, pregnancy risk index (PRI), and emergency contraception (EC) prescriptions among female adolescents accessing the emergency department (ED) for care.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study is a planned secondary analysis of a multicenter trial from April 2021 through April 2022 that used a tablet-based, content-validated, confidential sexual health survey at 6 urban, pediatric tertiary care EDs affiliated with the Pediatric Emergency Care Applied Research Network. Participants were individuals aged 15 to 21 years presenting to the ED who completed the confidential sexual health survey and indicated female sex assigned at birth and prior penile-vaginal sexual intercourse. Data analysis was performed from January 2023 to February 2024.
MAIN OUTCOMES AND MEASURES: The primary outcomes were the type and proportion of contraception use, the PRI, and provision of EC. Separate multivariable logistic regression models were performed to identify sociodemographic factors associated with these outcomes.
RESULTS: A total of 1063 participants (median [IQR] age, 17.5 [16.5-18.3] years) were included in this analysis; 219 (20.8%) identified as Hispanic, 464 (44.1%) identified as non-Hispanic Black, 308 (29.3%) identified as non-Hispanic White, and 61 (5.8%) identified as other races and ethnicities. In total, 756 participants (71.1%) reported contraception use during their last sexual encounter. Long-acting reversible contraception use (LARC) was the least used (164 participants [15.4%]), and 307 (28.9%) reported no contraception use. Sociodemographic factors associated with overall contraception use, and LARC use specifically, included insurance and race and ethnicity. The overall PRI was 7.89, or an expected 8 pregnancies per 100 female individuals per year. Although 108 participants (10.2%) were eligible for EC, EC was ordered for only 6 (5.6%) of those eligible.
CONCLUSIONS AND RELEVANCE: In this cross-sectional study of sexually active adolescents presenting to the ED, the majority of participants reported using at least 1 form of contraception; however, LARCs were the least used option, and 28.9% of participants reported no contraceptive use. The unintended pregnancy risk was almost 8% in the study population. Few patients eligible for EC received it. These data suggest a high need and potential opportunity for provision of contraception services in the ED setting.
参考来源
- Canter H, Reed J, Palmer C, et al. Contraception Use and Pregnancy Risk Among Adolescents in Pediatric Emergency Departments. JAMA Netw Open. 2024. PMID: 38941097. doi:10.1001/jamanetworkopen.2024.18213
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。